Investor Overview

Investor Overview

Xenon Pharmaceuticals at the 31st Annual Piper Jaffray Healthcare Conference
December 4, 2019 at 3:00 pm EST

Company Profile

We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy.

Copyright West LLC. Minimum 15 minutes delayed.

Upcoming Events
More events are coming soon.